Literature DB >> 32413384

Signaling through estrogen receptors modulates long non-coding RNAs in prostate cancer.

Simona Nanni1, Lorenza Bacci2, Aurora Aiello3, Agnese Re3, Chiara Salis2, Claudio Grassi4, Alfredo Pontecorvi5, Carlo Gaetano6, Antonella Farsetti7.   

Abstract

Prostate cancer (PCa) is a sex-steroid hormone-dependent cancer in which estrogens play a critical role in both initiation and progression. Recently, several long non-coding RNAs (lncRNAs) have been associated with PCa and are supposedly playing a pivotal role in the biology and progression of this type of cancer. In this review, we focused on some lncRNAs that are known for their androgen and estrogen transcriptional responsiveness in PCa. Specifically, we summarized recent pieces of evidence about lncRNAs NEAT1, H19, MALAT1, and HOTAIR, in estrogen signaling, emphasizing their role in PCa progression and the acquisition of a castration-resistant phenotype. Here, the reader will find information about lncRNAs present in estrogen-dependent transcriptional complexes. The potential role of lncRNA/estrogen signaling as a novel pathway for PCa treatment will be discussed.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aging; Biomarkers; Chronic disease; Estrogen; Estrogen receptor; Long non-coding RNAs; Metastasis; Prostate cancer; Transcription; Tumor progression

Mesh:

Substances:

Year:  2020        PMID: 32413384     DOI: 10.1016/j.mce.2020.110864

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  5 in total

1.  Transcriptome profiling of kisspeptin neurons from the mouse arcuate nucleus reveals new mechanisms in estrogenic control of fertility.

Authors:  Balázs Göcz; Éva Rumpler; Miklós Sárvári; Katalin Skrapits; Szabolcs Takács; Imre Farkas; Veronika Csillag; Sarolta H Trinh; Zsuzsanna Bardóczi; Yvette Ruska; Norbert Solymosi; Szilárd Póliska; Zsuzsanna Szőke; Lucia Bartoloni; Yassine Zouaghi; Andrea Messina; Nelly Pitteloud; Ross C Anderson; Robert P Millar; Richard Quinton; Stephen M Manchishi; William H Colledge; Erik Hrabovszky
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-28       Impact factor: 12.779

2.  Long Non-Coding RNA DARS-AS1 Contributes to Prostate Cancer Progression Through Regulating the MicroRNA-628-5p/MTDH Axis.

Authors:  Haitao Fan; Junhui Hou; Siqing Liu; Zuomin Xiao; Jia Cui
Journal:  Cancer Manag Res       Date:  2020-09-10       Impact factor: 3.602

3.  Four Immune-Related Long Non-coding RNAs for Prognosis Prediction in Patients With Hepatocellular Carcinoma.

Authors:  Muqi Li; Minni Liang; Tian Lan; Xiwen Wu; Wenxuan Xie; Tielong Wang; Zhitao Chen; Shunli Shen; Baogang Peng
Journal:  Front Mol Biosci       Date:  2020-12-08

Review 4.  Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment.

Authors:  Dali Tong
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 13.751

5.  Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1.

Authors:  Peng Xue; Miao Yan; Kunpeng Wang; Jinbao Gu; Bing Zhong; Chuanquan Tu
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.